| 1 |
In a cohort of individuals with type 2 diabetes using the drug sulfasalazine, HbA
1c
lowering is associated with haematological changes |
|
|
| Samira M. S. N’Dow,Louise A. Donnelly,Ewan R. Pearson,Graham Rena |
|
| Diabetic Medicine. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Carassius auratus as a novel model for the hyperglycemia study |
|
|
| H. I. Falfushynska,O. I. Horyn,L. L. Gnatyshyna |
|
| The Ukrainian Biochemical Journal. 2019; 91(4): 58 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone |
|
|
| Elisa Molinelli,Matteo Paolinelli,Anna Campanati,Valerio Brisigotti,Annamaria Offidani |
|
| Expert Opinion on Drug Metabolism & Toxicology. 2019; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Falsely Decreased HbA1c in a Type 2 Diabetic Patient Treated with Dapsone |
|
|
| Arti D. Shah,Rena K. Fox,Robert J.Rushakoff |
|
| Endocrine Practice. 2014; 1(-1): 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
1-Hour Venous Plasma Glucose and Incident Prediabetes and Diabetes in Asian Indians |
|
|
| Miranda Priya,Ranjit Mohan Anjana,Faraja S. Chiwanga,Kuppan Gokulakrishnan,Mohan Deepa,Viswanathan Mohan |
|
| Diabetes Technology & Therapeutics. 2013; 15(6): 497 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Challenges in Estimation of Glycated Hemoglobin in India |
|
|
| Ranjit Unnikrishnan,Viswanathan Mohan |
|
| Diabetes Technology & Therapeutics. 2013; 15(10): 897 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
